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Abstract
Background: Tumor burden can be pharmacologically controlled by inhibiting cell division and by
direct, specific toxicity to the cancerous tissue. Unfortunately, tumors often develop intrinsic
pharmacoresistance mediated by specialized drug extrusion mechanisms such as P-glycoprotein. As
a consequence, malignant cells may become insensitive to various anti-cancer drugs. Recent studies
have shown that low intensity very low frequency electrical stimulation by alternating current (AC)
reduces the proliferation of different tumor cell lines by a mechanism affecting potassium channels
while at intermediate frequencies interfere with cytoskeletal mechanisms of cell division. The aim
of the present study is to test the hypothesis that permeability of several MDR1 over-expressing
tumor cell lines to the chemotherapic agent doxorubicin is enhanced by low frequency, low
intensity AC stimulation.
Methods: We grew human and rodent cells (C6, HT-1080, H-1299, SKOV-3 and PC-3) which
over-expressed MDR1 in 24-well Petri dishes equipped with an array of stainless steel electrodes
connected to a computer via a programmable I/O board. We used a dedicated program to generate
and monitor the electrical stimulation protocol. Parallel cultures were exposed for 3 hours to
increasing concentrations (1, 2, 4, and 8 µM) of doxorubicin following stimulation to 50 Hz AC (7.5
µA) or MDR1 inhibitor XR9576. Cell viability was assessed by determination of adenylate kinase
(AK) release. The relationship between MDR1 expression and the intracellular accumulation of
doxorubicin as well as the cellular distribution of MDR1 was investigated by computerized image
analysis immunohistochemistry and Western blot techniques.
Results: By the use of a variety of tumor cell lines, we show that low frequency, low intensity AC
stimulation enhances chemotherapeutic efficacy. This effect was due to an altered expression of
intrinsic cellular drug resistance mechanisms. Immunohistochemical, Western blot and
fluorescence analysis revealed that AC not only decreases MDR1 expression but also changes its
cellular distribution from the plasma membrane to the cytosol. These effects synergistically
contributed to the loss of drug extrusion ability and increased chemo-sensitivity.
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Conclusion: In the present study, we demonstrate that low frequency, low intensity alternating
current electrical stimulation drastically enhances chemotherapeutic efficacy in MDR1 drug
resistant malignant tumors. This effect is due to an altered expression of intrinsic cellular drug
resistance mechanisms. Our data strongly support a potential clinical application of electrical
stimulation to enhance the efficacy of currently available chemotherapeutic protocols.
Background
Multidrug resistance is often the result of overexpression
of membrane glycoproteins known as P-glycoprotein (P-
gp) [1]. In humans, the drug transporter P-gp is encoded
by the MDR1 gene while two encoding genes Mdr1a and
Mdr1b, [2] are present in rodents. P-gp proteins belong to
the super family of ATP-binding cassette transporters [3].
MDR proteins recognize a wide range of substrates of
diverse chemical structure. This lack of substrate specifi-
city explains the cross-resistance to several chemothera-
peutic compounds, the characteristic clinical feature
found in a multi-drug resistance phenotype. In addition
to their overlapping substrate specificity, each transporter
can handle a variety of unique compounds.
Pgp-MDR1 has been identified as an obstacle to both
peripheral and CNS chemotherapy [4,5]. Thus, drug
refractory tumors present a clinical challenge which
requires novel treatment modalities [6,7]. In fact, despite
recent advances in chemotherapy, the true potential of
new agents has not been realised due to the multitude of
resistance pathways that impair chemotherapeutic effi-
cacy. Taken together, these findings demonstrate that: 1)
MDR is often an insurmountable impediment to cancer
chemotherapy; 2) In the case of brain tumors, MDR1 acts
by a dual mechanism: a pharmacokinetic one mediated
by endothelial cells at the blood-brain barrier and a phar-
macodynamic one at the tumor cell plasma membrane
where multidrug resistant transporters are widely
expressed.
Limitations of current therapies are well known and still
far from being addressed. For example, radiotherapy pro-
duces its biologic effect on cancerous tissue by ionization.
Radiation therapy is carried out by megavolt energy radi-
ation in the form of X-rays from a linear accelerator or
gamma rays from a cobalt source. Radiation is highly pen-
etrating, but in order to reach the region of the tumor
being treated, the radiation beam must pass through
regions containing healthy tissue and may therefore
destroy these as well as the malignant tumor. Chemother-
apy is limited by drug resistance [1,7,8] and by the fact
that malignant and non-malignant cells are so similar that
it is difficult to destroy cancerous cells without concur-
rently destroying healthy cells. The adverse effects of
chemotherapy are notorious. Increasing the temperature
of the tumor to a level at which cancerous cells are
destroyed can be used to destroy malignant tumors. One
method used for this purpose is to focus a beam of micro-
wave energy, of the type generated in a microwave oven,
onto the tumor. The drawback of this technique is that
healthy tissues through which the beam must pass to
reach the tumor have higher moisture content than the
interior of the tumor and are therefore more reactive to
microwave energy. Surgical approaches to excise a malig-
nant tumor are limited by location of the tumor, as in the
case of tumors in the brain, which are often inoperable.
But even where the tumor is accessible, residual malignant
cells are left behind, leading to recurrence.
Other approaches include the electrical stimulation in or
around the tumor [9,10], biological response monitors, or
specific MDR1 inhibitors such us Tariquidar (XR9576)
[11]. In an electrochemical procedure [10,12], electrodes
are implanted in or around the malignant tumor to be
treated. The treatment lasts for several hours during one or
more sessions and can be used either alone or in conjunc-
tion with other therapy such as chemotherapy or radia-
tion therapy. Applied across these electrodes is a low DC
voltage of about 6 ± 10 V with currents of 40 ± 100 mA,
causing a current to flow between the platinum electrodes
through the tumor. The exposure of living tissue to this
electric field leads to a wide range of effects such as: 1)
Water migrates from the anode to the cathode; 2) The
"anodic site" in the tissue becomes strongly acidic and the
cathodic site strongly alkaline; 3) Protein denaturation; 4)
Bleaching of the local tissue and 5) Cell metabolism and
its existing environment are disturbed severely by the elec-
trochemical treatment, causing the destruction of both
normal and tumor cells rapidly and completely
[10,12,13].
More recently [see Additional file 1], very low-intensity (<
15 µA), low frequency AC (50 HZ) applied to dividing
cells was shown to inhibit the cell cycle by affecting potas-
sium channels [14] while another study has revealed that
at low-intensity, intermediate-frequency (100 – 300 kHz)
AC electrical fields may interfere with cytoskeletal mecha-
nisms responsible for the formation of mitotic spindles
[15], thus preventing tumor proliferation. In this context
however, a cytostatic effect is not sufficient to decrease
tumor burden if chemotherapy is ineffective. We now
describe a new approach based on delivery of low fre-
quency, low intensity AC stimuli directly to the tumorBMC Cancer 2006, 6:72 http://www.biomedcentral.com/1471-2407/6/72
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cells to achieve increased sensitivity to common chemo-
therapic agents in spite of robust MDR1 expression.
Methods
Cell culture and electrical stimulation set up
Rat glioma C6 (Cat# CCL-107), prostate tumor (PC-3,
Cat# CRL-1435), lung tumor (H1299 Cat# CRL-5803),
fibrosarcoma (H1080 Cat# CRL-12012) and ovarian can-
cer (SKOV-3 Cat# HTB-77) cell lines were purchased from
ATCC and characterized for MDR1 expression. Cells were
initially expanded in Dulbecco's modified essential
medium (DMEM-F12) supplemented with 2 mM
glutamine, 10% fetal bovine serum (FBS), 100 units of
penicillin G sodium per ml, and 100 µg of streptomycin
sulfate per ml. All cells were maintained at 37°C in a
humidified atmosphere consisting of 5% CO2 and 95%
air. The cells were seeded into pre-coated (3 µg/cm2 Poly-
d-Lysine) 24 well plates with average seeding density
being 1 × 104 cells/cm2 in every experiment. Well plates
were engineered to accommodate stainless steel elec-
trodes, which were connected to a computer controlled
waveform generator via a programmable I/O board. We
used a dedicated program to generate and monitor the
electrical stimulation protocol. Cultures were stimulated
for 3 days after the initial cell seeding. Media samples were
taken on a daily basis and processed for AK measure-
ments. Cellular growth was monitored every day by
inspection with phase contrast microscopy.
Choice of the electrical stimulation paradigms
Cells undergoing stimulation protocols were exposed to
50 Hz AC (7.5 µA 32 cycles/pulse, 10 sec interval between
pulses) for three days. The stimulation paradigms pre-
sented herein (frequency, intensity interstimulus interval)
originate from a previous study [see Additional file 1]
aimed at demonstrating the cytostatic effect promoted by
the exposure to AC current of tumor cell lines. We shown
that cells exposed to AC stimulation at 10 Hz, ≈ 10 µA for
2 to 5 days grew at a rate similar to non-stimulated con-
trols. In contrast, stimulation at 25 – 100 Hz caused a pro-
nounced decrease in cell proliferation as early as three
days after stimulation. The effects persisted and amplified
with prolonged exposure to electric pulses. However,
while stimulation up to 50 Hz decreased cell number
through a direct effect on cell cycle, at frequencies greater
than 50 Hz and or intensities greater than 15 µA the effect
on cell proliferation significantly overlapped with a cyto-
toxic one on both tumors and normal cells. In view of a
possible clinical application of this novel approach, limi-
tation of peripheral "normal" cells damage due to a possi-
ble exposure to the electric field was vital to our project
and was as well an element of distinction from the classi-
cal electrochemical protocol.
Cell isolation, characterization and primary culture
MDR1 over-expressing astrocyte cultures were established
from human cerebral cortical tissue of patients undergo-
ing temporal lobectomies to relieve medically intractable
seizures. Brain resections were collected in an ice-cold arti-
ficial cerebrospinal fluid solution bubbled with 5%
CO2and 95% O2. This solution consisted of (in mM): 120
NaCl, 3.1 KCl, 3 MgCl2, 1 CaCl2, 1.25 KH2PO4, 26
NaHCO3, 10 dextrose. Briefly, tissue was homogenized
for 20 min. at 37°C after gentle trituration and incubation
in phosphate buffer saline (PBS) containing trypsin
(0.2%)/DNase (1 mg/ml, Sigma-Aldrich, MO, USA). After
centrifugation (200 g for 5 min.) and filtration through 70
µm nylon sieve, cells were seeded in appropriated poly-D-
lysine coated flask. The culture medium consisted of Dul-
becco's modified essential medium (DMEM) supple-
mented with 10% FBS and 2 mM glutamine, 100 U/ml
penicillin G sodium and 100 µg/ml streptomycin sulfate.
Immunological characterization was performed with rab-
bit polyclonal antibodies that recognize the glial marker
GFAP (Dako Corporation, Carpentaria, CA, USA) and
with human anti-P-Glycoprotein polyclonal antibody
(1:100, Calbiochem-Novabiochem Corporation, San
Diego, CA, USA) to assess for MDR1 expression. Normal
astrocytes from ScienCell (Cat# 1810), were used as con-
trol (Normal Astro).
Current density calculation
The peak surface current density was calculated by an
automated 2-D finite-elements approximation of the sys-
tem. In the frequency range of interest, the system can be
considered purely resistive due to the lack of inductive or
capacitive effects, thus allowing the use of a simplified
model. Each well or Petri dish was divided into 360 sub-
elements, and Kirchhoff's laws applied according to: ∑I =
0 (for every node) and ∑V = 0 (for every closed loop). The
resulting current, divided by the element area, allowed the
calculation of the surface current density.
Adenylate Kinase measurement
Detection of cytotoxicity and cytolysis was assessed by
measurement of AK release. Media samples were taken
before and after the experiment. The measurements were
performed by the use of the ToxiLight™ HS kit (Cambrex
Bio Science Rockland, Inc.). The assays were conducted at
ambient temperature (18–22°C) following the procedure
described by the manufacturer. In brief, the assay method
involves the release the AK into the surrounding matrix
whenever cell damage occurs and the integrity of the
plasma membrane is compromised. The AK enzyme fol-
lowing the introduction of an excess of ADP then gener-
ates ATP. Luciferase/luciferin is added to the sample, light
is emitted in the presence of the ATP and the photon emis-
sion is measured using a luminometer.BMC Cancer 2006, 6:72 http://www.biomedcentral.com/1471-2407/6/72
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MDR1 immunohistochemical detection and distribution
To investigate the expression of MDR1 protein and its
localization, cells were cultured on poly-d-lysine pre-
coated slides. The slides were positioned in the electrified
well plate and stimulated for 3 days. Cells were fixed in
4% formaldehyde at room temperature for 20 minutes
and then washed three times with 1× PBS. Blocking was
performed at room temperature for 1 h with: 0.3% Triton-
X, 3% bovine serum albumin, 3% normal goat serum and
1× TBS. The primary antibody used was Anti-P-Glycopro-
tein (C494) hamster and human (mouse) monoclonal
(1:40; Calbiochem, San Diego, California). The secondary
antibody used was Fluorescein (FITC)-conjugated affin-
ipure donkey anti-mouse IgG (1:200; Jackson Immunore-
search Laboratories, West Grove, Pennsylvania). Cellular
distribution of MDR1 was assessed with the use of a 35-
mm camera mounted on a fluorescent microscope unit
(Leica Leitz DM-RXE) and interfaced to a PC (using Qcap-
ture software – Quantitative Imaging Company). The
images were analyzed by Phoretix 2D Image Analysis Soft-
ware. Data were further analyzed using Origin Lab 7 soft-
ware. Experiments were performed in triplicate.
Doxorubicin uptake measurement, toxicity and cell 
viability
Parallel 24 well plate cultures (stimulated; pre-treated
with the MDR1 blocker XR9576 [20 nM] and a control)
were used in triplicates per each tumor cell type. Cells
were exposed to different concentrations (1, 2, 4 and 8
µM) of doxorubicin for 3 hours. Media samples were col-
lected before and after the exposure to doxorubicin to
assess for AK release. Media containing doxorubicin was
then washed out and replaced with cold media and kept
at 4°C in order to inhibit MDR1 activity [16,17]. Cells
were then exposed to Calcein (Calcein AM Fluorogenic
Esterase Substrate Cell Viability and Cytotoxicity kit -Inv-
itrogen, Carlsbad – CA, USA) according to the manufac-
turer protocols and specifications to assess for cell
viability. In the absence of efflux activity, free calcein accu-
mulates within the cell resulting in a 100- to 500-fold
increase in the intracellular concentration of the dye and
bright fluorescence exhibited by living target cells. Cell
viability and quantification of the intracellular levels of
doxorubicin were assessed by measurement of fluores-
cence intensity and compared to parallel XR9576-treated
cultures and controls. Data were analyzed by Phoretix 2D
Image Analysis Software and Origin Lab 7. The final
experiment with normal and MDR1 over-expressing astro-
cytes was performed by increasing the concentration of
XR9576 to 1 µM.
Isolation of cellular fractions
Extraction of proteins from stimulated and control cell
cultures were performed by the use of ProteoExtract Sub-
cellular Proteome Extraction Kit (EMD Biosciences San
Diego, CA Cat# 539790) designed for fast and reproduci-
ble extraction of subcellular proteomes from mammalian
tissue and adherent and suspension-grown cells. In the
specific case of adherent cells, the procedure is performed
directly in the tissue culture dish without the need for cell
removal. Cells or the parts of the cells remain attached to
the plate during sequential extraction of subcellular com-
partments until the appropriate extraction reagent is used.
Thus, the early destruction of the cellular structure by
enzymatic or mechanical detachment of cells from the tis-
sue culture plate and any mixing of different subcellular
compartments is prevented. The assay was performed fol-
lowing the procedure described by the manufacturer. The
stepwise extraction delivers four distinct protein fractions
from one sample: 1) Cytosolic protein fraction; 2) Mem-
brane/organelle protein fraction; 3) Nuclear protein frac-
tion; 4) Cytoskeletal protein fraction. Proteins were
obtained in the native state and processed for Western
blot and protein analysis.
Western Blot Analysis
Proteins differentially extracted from stimulated and con-
trol cells were re-dissolved in RIPA buffer containing pro-
tease inhibitors (0.17 mg/mL PMSF, 2 µg/mL leupeptin,
and 0.7 µg/mL aprotinin). Prior to electrophoresis, pro-
tein extracts were denatured by heating at 100°C for 5
minutes in a running buffer solution containing RIPA, β-
mercaptoethanol, and bromophenol blue tracking dye.
15 µg proteins were loaded in each lane. Duplicate acryla-
mide gels (12%, precast gels; Bio-Rad Labs, Hercules, CA)
were run for 2.5–3 hrs at constant voltage (80 V) until the
bromophenol blue tracking dye migrated to the bottom
edge of the gels. Proteins were then transferred onto a blot
of PVDF using constant current (40 mA) overnight at 4°C.
Proteins were probed overnight at 4°C with primary
MDR1 mouse anti-human antibody (1:100; Calbiochem
Clone C494, San Diego, CA). Blots were washed and
treated with rabbit anti-mouse IgG HRP conjugated sec-
ondary antibody (1:5000; Dako Corp., Carpinteria, CA).
To ensure that the same amount of total protein was elec-
troblotted, PVDF membranes were incubated for 20 min-
utes at 37°C in a "stripping buffer" (Restore Western Blot
Stripping Buffer, Pierce, Rockford, IL). Non-specific bind-
ing blocking was performed as described above; mem-
branes were reprobed with monoclonal anti β-Actin
antibody (1:10,000, Clone AC-15, Sigma-Aldrich, St.
Louis, MO). Protein bands were analyzed by Phoretix 2D
Image Analysis Software and Origin Lab 7.
Results and discussion
Cells undergoing stimulation protocols were exposed to
50 Hz AC (7.5 µA 32 cycles/pulse, 10 sec interval between
pulses) for three days as described in the method section.
We have previously shown that this stimulation paradigm
is devoid of temperature-dependent effects, is not cyto-BMC Cancer 2006, 6:72 http://www.biomedcentral.com/1471-2407/6/72
Page 5 of 12
(page number not for citation purposes)
Blockade of MDR1 by either XR9576 or electrical stimulation increases doxorubicin uptake Figure 1
Blockade of MDR1 by either XR9576 or electrical stimulation increases doxorubicin uptake. Calcein stains (green 
fluorescence) cells that retain intact membrane structure, but it does not label dead cells and is rapidly lost under conditions 
that cause cell lyses. Doxorubicin (in red) is normally extruded by drug resistant mechanisms and thus enters untreated cells 
reluctantly. Note that exposure to either MDR blocker or electrical stimulation achieved a greater uptake of red fluorescent 
doxorubicin and dramatically decreased the number of viable cells (in green). Small diagram: In viable cells, hydrolysis of Cal-
cein-AM by intracellular esterases produces fluorescent calcein that is retained in the cell cytoplasm. Exposure to AC stimula-
tion increases doxorubicin cytotoxicity thus compromising cell viability and esterases activity.BMC Cancer 2006, 6:72 http://www.biomedcentral.com/1471-2407/6/72
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AC stimulation enhance doxorubicin efficacy Figure 2
AC stimulation enhance doxorubicin efficacy. (a) Determination of doxorubicin toxicity by AK. As doxorubicin concen-
tration increased, cells underwent significant detrimental changes. These were further increased by either MDR1 blockade or 
electrical stimulation. The asterisk refers to a statistical significant difference (n = 10; p = 0.028 by ANOVA) with non-stimu-
lated cultures while the positive sign refers to statically significant differences (n = 10; p = 0.036) with cultures exposed to 
XR9576. Note that AC stimulation or exposure to XR9576 does not cause any cytotoxic effect in comparison to non-treated 
(control) cultures. (b) Quantitative analysis of the experiment shown in figure (1), including adult response for the chemother-
apeutic agent doxorubicin. Note that electrical stimulation achieved an equal or greater effect than blockade of MDR1 by 
XR9576. The asterisk indicates a significant difference (n = 10; p = 0.023 by ANOVA) from controls whereas the sign plus sym-
bolizes significant difference (n = 10; p = 0.031) from XR-treated cultures. Data points were fitted by the following sigmoid: 
Equation: y = A2 + (A1-A2)/(1 + (x/x0)^)BMC Cancer 2006, 6:72 http://www.biomedcentral.com/1471-2407/6/72
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Inverse correlation between the expression of MDR1 and the intracellular uptake of doxorubicin Figure 3
Inverse correlation between the expression of MDR1 and the intracellular uptake of doxorubicin. (a) Micro photographs 
showing the accumulation of doxorubicin (in red) in cells also stained for MDR1 immunoreactivity (in green). Note that electri-
cal stimulation greatly increased the accumulation of doxorubicin in the cell nucleus while achieving a proportionate decrease 
of immunological reactive signal for MDR1. (b) Data summarizing the inverse relationship between MDR1 expression and dox-
orubicin uptake.BMC Cancer 2006, 6:72 http://www.biomedcentral.com/1471-2407/6/72
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Cellular MDR1 distribution is modulated by electrical stimulation Figure 4
Cellular MDR1 distribution is modulated by electrical stimulation. a) The upper panel shows the immunocyto-
chemical analysis of sub-cellular expression of MDR1. Note that prior to stimulation, MDR1 was primarily located in proximity 
of the plasma membrane. In stimulated cells, however, MDR immunosignal significantly shifted towards the center of the cell, 
suggesting a cytoplasmic or nuclear localization. Quantification was achieved by plotting the levels of expression against cell 
diameter; the dotted red lines show these relationships. Western blot analysis (lower panel) of sub-cellular fractions of cell 
types used for the experiments. Note that electrical stimulation caused a dramatic shift of membrane-bound MDR1 towards 
the cytosolic compartment. The numbers to the right show fold changes after electrical stimulation. b) Immunocytochemical 
analysis of MDR1 sub-cellular expression 48 hours post stimulation. Note that the effect of AC stimulation on MDR1 is revers-
ible. Cells previously exposed to AC field demonstrating MDR1 cytosolic accumulation now replicates generating "normal" 
MDR1 + cells.BMC Cancer 2006, 6:72 http://www.biomedcentral.com/1471-2407/6/72
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toxic and specifically does not disrupt cell membrane
integrity [14]. After 72 hours of continuous stimulation,
cells were exposed for 3 hours to increasing concentra-
tions (1, 2, 4, and 8 µM) of doxorubicin, an MDR1 sub-
strate and potent chemotherapeutic drug to which these
cell lines are exquisitely resistant (e.g., HL-60 cells) [18].
Cell viability was assessed by determination of adenylate
kinase (AK) release [19] and calcein uptake [20]. Since cal-
cein is a well known MDR1 substrate, this latter experi-
ment was carried out at 4°C in order to inhibit MDR1
activity [17], allow for intracellular accumulation of cal-
cein and assess for cell viability as described in the
method section. The results shown in Figure 1a demon-
strate that AC stimulation increased doxorubicin uptake
(in red) leading to increased cell damage even at low con-
centrations as demonstrated by AK release measurements
(Figure 2a). The sensitivity of this method is improved
due to the equilibrium reaction being artificially driven to
overproduce ATP by the addition of an excess of ADP.
Moreover, unlike traditional ATP assays, AK levels are con-
stant and do not fluctuate with metabolic state, providing
a more reproducible, quantifiable signal which closely
correlates with cell numbers. These features enable small
changes in the cell population to be detected.
The effects of AC stimulation on cell viability were com-
pared to those of the MDR1 inhibitor XR9576 (20 nM)
[11,21] concomitantly applied to doxorubicin. We found
that AC stimulation affected cell survival more potently
than pre-treatment with the MDR1 inhibitor. This was
demonstrated by the analysis of cell cultures exposed to
fluorescent doxorubicin followed by calcein uptake at low
temperature. The effect of AC stimulation on cell viability
is particularly evident at low doses of doxorubicin (1 and
2 µM, Figure 2b), since the differences were less obvious
at higher concentrations of doxorubicin. The fact that 20
nM concentrations of XR exhibited an effect on cell viabil-
ity capable of greatly enhancing the toxicity of doxoru-
bicin suggest two things: 1) The intrinsic resistance to
doxorubicin was almost entirely overridden by the spe-
cific MDR1 blocker XR9576 thus ruling out a significant
contribution of MRP and 2) That the electrical stimulation
applied had an effect much greater than that of XR9576
applied at EC50 level. Taken together these considerations
imply that had we used much higher concentration of
XR9576 we would have achieved the same effect as with
electrical stimulation.
Immunohistochemical and fluorescence analysis of cells
exposed to doxorubicin following AC stimulation
revealed a significant decrease in MDR1 expression paral-
leled by an increased intracellular uptake of doxorubicin
(Figure 3a). Figure 3b shows the relationship between
MDR1 expression and the intracellular accumulation of
doxorubicin. As expected in control cells the binding of
Doxorubicin was nuclear, presumably involving DNA or
other nuclear material. These bindings are not easily
reversed, and therefore one expects persistence of the Dox-
orubicin signal even after manipulation of the cell mem-
brane. We have used the same immunocytochemical
approach to process cells prior and after stimulation. As
can be clearly seen in figure 3a, following AC stimulation
and under reduced MDR1 load increased Doxorubicin
binding to the nuclear material was observed.
When the cellular distribution of MDR1 was investigated
by computerized image analysis and immunohistochem-
istry, we discovered that AC stimulation not only
decreased the expression of MDR1, but also altered its
sub-cellular distribution. In non-stimulated cultures,
MDR1 was found to be primarily expressed close to the
plasma membrane [22], while in stimulated cultures we
observed MDR1 expression predominantly in the
cytosolic compartment (Figure 4a). The change in MDR1
distribution was indeed confirmed by Western blot analy-
sis performed on membrane and cytosolic protein frac-
tions (Figure 4a lower panel). This shift toward the
cytosolic compartment may explain the loss of drug extru-
sion potency.
While one is tempted to presume that what happened is
translocation from the membrane to the cytosol, our cur-
rent hypothesis is that electrical stimulation achieved the
opposite effect, for example impeding release of MDR1
from the cytosolic protein synthesis machinery and thus
preventing correct insertion in the membrane. This seems
to be so far the more appropriate explanation since the
effects of electrical stimulation become evident only after
several proliferative cycles (approximately 2 days). Fur-
thermore, as shown in figure 4b the effects of AC stimula-
tion are reversible. Cell cultures that have been exposed to
the AC protocol for 3 day and then allowed to rest for 48
h demonstrate a mixed population of cells where the func-
tional MDR1 distribution appears to be partially restored.
It is also to be noted that AC stimulation concurrently
decreases cell proliferation as demonstrated in our previ-
ous work [14]. This explains the apparently long exposure
time to AC electric field required for the stimulation to
achieve an effect (3 days) and the relatively long time for
the cells to recover.
Ideally, a chemotherapeutic approach achieves high levels
of target toxicity while sparing normal, healthy cells. In
order to evaluate the specificity of AC for drug resistant
cells, human brain astrocytes (non-MDR1 over-express-
ing) and drug-resistant, MDR1 over-expressing astrocytes
isolated from drug refractory epileptic patients were
exposed to doxorubicin (1 µM) for 3 hours following
stimulation or pre-treatment with XR9576 at EC50 (20
nM) and over-saturating levels (1 µM) [21]. No significantBMC Cancer 2006, 6:72 http://www.biomedcentral.com/1471-2407/6/72
Page 10 of 12
(page number not for citation purposes)
differences of drug uptake were detected in normal astro-
cytes undergoing AC stimulation in comparison to con-
trol or XR9576-treated cultures (Figures 5a). However,
MDR1 over-expressing astrocytic cultures exposed to the
same experimental paradigms showed drug uptake pat-
terns similar to that observed in tumor cell cultures. These
data demonstrate that low frequency, low intensity AC
stimulation is only effective when drug uptake is limited
by MDR1 (Figure 5b).
In summary, we have shown that in addition to a cyto-
static effect, AC stimulation also causes the accumulation
of MDR1 protein into the cytosol (a non-functional place-
ment) in disfavour of their functional localization on the
plasma membrane. In addition, overall MDR1 expression
Electrical stimulation selectively increased chemotherapeutic efficacy in drug resistant cells Figure 5
Electrical stimulation selectively increased chemotherapeutic efficacy in drug resistant cells. (a) Doxorubicin 
uptake in normal human astrocytes versus MDR1 over-expressing glial cells isolated from patients with multiple drug resistant 
epilepsy. Note that electrical stimulation and MDR1 blockade by XR9576 (20 nM and 1 µM) significantly increased doxorubicin 
uptake in MDR1+ cells compared to controls while normal astrocytes were virtually unaffected as confirmed by quantitative 
analysis (n = 10; p = 0.017). Note that the effect of AC stimulation on Doxorubicin uptake is comparable to the effect of XR 
used at a final concentration of 1 µM where full MDR1 blockade was achieved. (b) Estimation of lethal concentration of doxo-
rubicin under different experimental conditions. Normal astrocytes were virtually insensitive to electrical stimulation and 
MDR1 blockade by XR9576 at all concentrations of doxorubicin tested. In contrast, MDR1 expressing glial cells responded to 
ES or MDR1 blockade. Note that a concentration of 20 nM of XR9576 corresponds to EC50. The final concentration of XR 
used for the comparison (1 µM) was approximately three times higher that the concentration required to achieve full blockade 
of the MDR1 transporters. The asterisk indicates a significant difference (n = 10; p < 0.022 by ANOVA) from controls whereas 
the sign plus symbolizes significant difference (n = 10; p < 0.027) from XR-treated cultures. Data points were fitted by the fol-
lowing sigmoid: Equation: y = A2 + (A1-A2)/(1 + (x/x0)^).BMC Cancer 2006, 6:72 http://www.biomedcentral.com/1471-2407/6/72
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was decreased in stimulated cells. These effects increased
the cellular uptake of MDR1 drug substrates and ulti-
mately boosted chemotherapic efficacy. The molecular
mechanisms of this effect are yet unknown. There are sev-
eral possible explanations including the potential involve-
ment of a cytoskeletal mechanism in intracellular protein
trafficking. The possibility that electrical stimulation
inhibits the correct positioning of MDR1 in the cell mem-
brane is supported by findings by others showing that
electrical stimulation can affect microtubular structural
assembly and spindle formation [15]. Based on this
hypothesis, it is possible that MDR1 remains bound to
either ribosomal proteins or other cytoplasmic compart-
ments. Another significant finding of the study is the spe-
cificity of AC stimulation for cells expressing MDR1.
Electrical stimulation did not increase the sensitivity of
normal (non-drug resistant) cells to doxorubicin thus
excluding the possibility that AC affects plasma mem-
brane integrity. Furthermore, since several proliferative
cycles are required in order for AC to be effective, cells
which cell cycle is slow or almost inexistent (e.g. neurons)
in comparison to tumors are practically unaffected by the
exposure to the electric field. In addition to that, the effect
of AC stimulation on the intrinsic drug resistance is revers-
ible as is its anti-proliferative effect.
Conclusion
The main finding presented here is that very low intensity
AC current delivered in the proximity of malignant
tumors can reduce drug resistance by a mechanism impli-
cating impaired translocation of MDR1 to its functional
localization at the plasma membrane. In addition, as pre-
viously demonstrated [14] the same stimulation protocol
promotes a cytostatic effect reducing tumor cells prolifer-
ation. These findings suggest a potential application of
low intensity AC current in the treatment of tumor growth
by synergistically reducing neoplastic cell division and
intrinsic tumor drug resistance. In view of the widespread
use of stimulators and stimulating electrodes for the treat-
ment of a variety of other diseases (such as treatment-
resistant depression, epilepsy and Parkinson) [23-26], it
seems possible that coupling electrical stimulation to cur-
rent chemotherapy protocols will improve the efficacy of
our therapeutic approach to neoplasms. AC stimulation
may also decrease the quantity of chemotherapic drugs
required to reduce tumor burden. This should reduce
chronic exposure to chemotherapic agents as well as the
side effects typically associated to chemotherapy. It is also
to be noted that both the cytostatic effect and the reduced
drug resistance are fully reversible.
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